The value of lowering cholesterol after myocardial... [N Engl J Med. 1990]

Cited by 17 PubMed Central articles

ReviewImplications of the obesity epidemic for lipid-lowering therapy: non-HDL cholesterol should replace LDL cholesterol as the primary therapeutic target.
Hoenig MR. Vasc Health Risk Manag. 2008; 4(1):143-56.

[Vasc Health Risk Manag. 2008]
ReviewEffects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials.
Strippoli GF, Navaneethan SD, Johnson DW, Perkovic V, Pellegrini F, Nicolucci A, Craig JC. BMJ. 2008 Mar 22; 336(7645):645-51. Epub 2008 Feb 25.

[BMJ. 2008]
The effects of atorvastatin therapy on endothelial function in patients with coronary artery disease.
Yildiz A, Cakar MA, Baskurt M, Okcun B, Guzelsoy D, Coskun U. Cardiovasc Ultrasound. 2007 Dec 30; 5:51. Epub 2007 Dec 30.

[Cardiovasc Ultrasound. 2007]
» See all...

Related Articles
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Your browsing activity is empty.

Activity recording is turned off.